Letter to the Editor
Dear Editor, Krieves et al 1 reported, in their recent article, an interesting case of a patient with a complex clinical history, including aortoesophageal fistula (AEF) secondary to postcoarctation aortic aneurysm rupture. The authors conclude that early diagnosis of aortic coarctation is important and state that most patients require surgical repair. However, we would like to highlight that there are several reports of endovascular stents used as successful treatment of AEFs.
The AEF and aortobronchial fistula are an uncommon diseases. If untreated, mortality approaches 100% secondary to exsanguinating hematemesis. Early diagnosis and treatment are essential for survival. Open surgical repair is associated with high mortality rates, ranging from 25% to 41%, 2 and morbidity, primarily due to graft infection, prolonged ventilation, neurological sequelae, and reintervention. In our experience, thoracic endovascular aortic repair (TEVAR) provides a lifesaving and reliable method of treatment for AEF presenting with hematemesis, although additional follow-up is mandatory before this technique is demonstrated to be effective in the medium to long term. 3 In our opinion, TEVAR was a good choice of therapy, which allowed you to save the life of this young patient.
One potential life-threatening complication of TEVAR is stent-graft infection, which is also the case with open surgery and prosthetic graft interposition. Postoperative antibiotic treatment varies between institutions, both with regard to the choice of antibiotic (cephalosporin, vancomycin, antifungal) and the duration of therapy. In addition, the choice of imaging modality to diagnose infection is important. Computed axial tomography scan remains the gold standard, but nuclear medicine scans may have greater sensitivity using labeled leukocytes. [4] [5] [6] Could Krieves et al please comment on follow-up imaging used to screen for infection in this patient, the choice of antibiotics used, and duration of therapy?
